Tag: Biotechnology

Mogrify
Untied Kingdom

Mogrify Appoints Dr Jonathan Appleby as Chief Scientific Officer

Strategic hire bolsters executive leadership team as Company progresses multiple therapeutic programs toward and into clinical development. CAMBRIDGE, England – Mogrify Limited (Mogrify®), a regenerative medicine company developing a novel class of in vivo reprogramming therapies for diseases with high unmet clinical need, announces the appointment of Dr Jonathan Appleby as Chief Scientific Officer. With decades of industry experience in translating both conventional and advanced therapeutic medicines, … Continue reading Mogrify Appoints Dr Jonathan Appleby as Chief Scientific Officer

Impact Newswire
Ophirex
United States

Ophirex Appoints Jeremy Gowler as Chief Executive Officer

Gowler Brings More than 20 Years of Biopharmaceutical Industry Leadership to Ophirex, Strengthening its Late-Stage Development and Growth Strategy CORTE MADERA, Calif. – Ophirex, Inc., a registered Public Benefit Corporation developing an oral field treatment to address the global unmet medical needs of snakebite victims, today announced the appointment of Jeremy Gowler as chief executive officer. Mr. Gowler also joins the Ophirex Board of Directors. … Continue reading Ophirex Appoints Jeremy Gowler as Chief Executive Officer

Impact Newswire
AffyImmune
United States

AffyImmune Appoints Dr. Daniel Janse as Chief Executive Officer

NATICK, Mass. – AffyImmune, a clinical-stage biotechnology company committed to developing novel, first-in-class CAR T cell therapies, today announced the appointment of Daniel Janse, Ph.D. as President and Chief Executive Officer. Dr. Janse brings twenty years of expertise and an extensive background in biopharmaceutical research and development, operations, and leadership to drive the company forward. “We are thrilled to welcome Dr. Janse as the new … Continue reading AffyImmune Appoints Dr. Daniel Janse as Chief Executive Officer

Impact Newswire
United States

BPGbio Appoints Esteemed Cancer Researcher Dr. Dipanjan Chowdhury to Scientific Advisory Board

Appointment Enhances Leadership in Protein Homeostasis and Oncology Translational Medicine BOSTON – BPGbio, Inc., a leading biology-first, AI-powered, clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced the addition of Dr. Dipanjan Chowdhury, a distinguished cancer researcher, to its Advisory Board. With his extensive expertise in early translational research and a deep understanding of aggressive solid tumors, Dr. Chowdhury will provide valuable guidance to enhance … Continue reading BPGbio Appoints Esteemed Cancer Researcher Dr. Dipanjan Chowdhury to Scientific Advisory Board

Impact Newswire
BioLoomics
United States

BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs

Former CSO of Trilo Therapeutics and Research Fellow at AbbVie joins to lead BioLoomics’ pipeline and combine lysosome targeting antibodies with ADCs BOULDER, Colo. – BioLoomics, a biotechnology company that targets peptide-antibody chimeras to specific compartments inside of diseased cells, announced today that Kurt Gish, Ph.D., has joined as the Chief Scientific Officer. Dr Gish will focus on building the company’s pipeline of lysosomal targeting … Continue reading BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs

Impact Newswire
Radar Therapeutics
United States

Radar Therapeutics Raises $13.4M in Seed Funding to Develop Smart Programmable Medicines Using Molecular RNA Sensors

BERKELEY, Calif. – Radar Therapeutics, a biotech company developing smart programmable medicines, today announced the completion of an oversubscribed $13.4 million in seed financing led by NfX Bio. Major investors Eli Lilly and Company, Biovision Ventures, and KdT Ventures also joined the round, with participation from PearVC, BEVC and other investors. The financing will support advancement of Radar’s internal programs, team expansion and partnering. “Like … Continue reading Radar Therapeutics Raises $13.4M in Seed Funding to Develop Smart Programmable Medicines Using Molecular RNA Sensors

Impact Newswire
Vivodyne
United States

Vivodyne Appoints Julie O’Shaughnessy as Chief Operating Officer

PHILADELPHIA – Vivodyne, a pioneering biotech company that grows and tests on lab-grown human tissues to accelerate therapeutics discovery and development, today announced the appointment of Julie O’Shaughnessy as Chief Operating Officer. In her new role, Julie will oversee business operations, strategic planning, finance, people operations, and multisite expansion, driving the company’s operational excellence and strategic growth initiatives. “Julie has been instrumental in Vivodyne’s growth … Continue reading Vivodyne Appoints Julie O’Shaughnessy as Chief Operating Officer

Impact Newswire
Bruker
United States

Bruker Completes Asset Acquisition of NanoString Business

Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of life-science research solutions for spatial transcriptomics and gene expression analysis. “We have a proven track record in successfully integrating and nurturing … Continue reading Bruker Completes Asset Acquisition of NanoString Business

Impact Newswire